Jiri Klimes is currently the Associate Director of Pricing Reimbursement Access and Czechia & Slovakia Access Lead at Eli Lilly and Company, where they develop and implement market access strategies. They have held the position of President of the ISPOR chapter in the Czech Republic from 2021 to 2023 and continue to influence health economics at Charles University as a researcher and teacher. With a strong background in health outcomes and market access, Jiri has experience in various disease areas, including oncology and neurological disorders, and has developed numerous health economic models during their career. Jiri earned a PharmD and PhD in Social Pharmacy from Charles University in Prague and holds an MBA from Texas Wesleyan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices